NCT00713284View on ClinicalTrials.gov

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Renal Transplantation
Interventions
DRUG

sirolimus

Oral tablet(s) taken daily for 6 months; dose will be based on serum trough levels.

Trial Locations (1)

94115

California Pacific Medical Center; Barry S. Levin, MD Department of Transplantation, San Francisco

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

California Pacific Medical Center Research Institute

OTHER